HBIO
HARVARD BIOSCIENCE INC
Key Financials
Gross Profit
$49.9M
↓ 8.9%
Net Income
$-56700000
↓ 357.1%
Revenue
$86.5M
↓ 8.1%
Operating Income
$-48580000
↓ 682.2%
Shareholders' Equity
$13.7M
↓ 78.3%
EPS (Diluted)
$-1.28
↓ 357.1%
Total Assets
$80.1M
↓ 36.8%
Long-term Debt
$35.9M
↓ 2.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 9/22/2026 | View on SEC |
| 10-Q | 8/11/2026 | View on SEC |
| 8-K | 8/11/2026 | View on SEC |
| 8-K | 8/11/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/11/2026 | View on SEC |
| 4 | 6/11/2026 | View on SEC |
| 4 | 6/11/2026 | View on SEC |
| 4 | 6/11/2026 | View on SEC |
| S-8 | 6/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HBIO |
| Company Name | HARVARD BIOSCIENCE INC |
| CIK | 1123494 |
| Sector | Laboratory Analytical Instruments |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3826 |
| SIC Description | Laboratory Analytical Instruments |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 5088938999 |